Get the Stockscreener App
1.59
3.64%
-0.06
After Hours:
1.74
0.15
+9.43%
Gelteq Ltd stock is traded at $1.59, with a volume of 38,821.
It is down -3.64% in the last 24 hours and up +0.00% over the past month.
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
See More
Previous Close:
$1.65
Open:
$1.65
24h Volume:
38,821
Relative Volume:
4.98
Market Cap:
$15.01M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-31.17%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.57
$1.7798
1-Week Range:
$1.50
$2.42
52-Week Range:
$1.50
$2.99
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| GELS | 1.59 | 15.01M | 0 | 0 | 0 | 0.00 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Gelteq Ltd Stock (GELS) Latest News
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times
GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan
Argent Biopharma Lists New Shares on ASX - MSN
Biotech company Gelteq prices IPO at $4 per share - MSN
Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN
Maas Group Reports Record Results and Growth Strategy - MSN
Qualitas Limited Releases 2024 Governance Statement - MSN
Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha
WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN
Novatti Group Announces Hybrid Annual General Meeting - MSN
Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times
RooLife Group Announces AGM with Key Resolutions - MSN
Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN
Strike Resources Limited Announces Upcoming AGM Details - MSN
IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha
Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project
Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World
SkyView Investment Advisors LLC Boosts Stock Holdings in General Electric (NYSE:GE) - Defense World
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData
AST SpaceMobile registers shares in Antares reorg - MSN
Free Stock Market Newsletter | MarketBeat Daily Ratings - MarketBeat
Join the InvestorsHub Community - InvestorsHub
Gelteq Ltd Stock (GELS) Financials Data
There is no financial data for Gelteq Ltd (GELS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.79%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):